Pfizer has reported another increase in revenue and profit for its local operation.
The US-based multinational saw its New Zealand revenue rise from $395.3 million to $424.9m for the 12 months to November 30, 2022,
Pfizer-BioNTech COVID-19 vaccine (Comirnaty) doses being prepared by a clinician. Photo / Getty Images
Pfizer has reported another increase in revenue and profit for its local operation.
The US-based multinational saw its New Zealand revenue rise from $395.3 million to $424.9m for the 12 months to November 30, 2022,
Callum Mallett, chief operating officer, on what went wrong and what the company is doing to fix it. Video / Michael Craig